Zydus Lifesciences Ltd received final approval from the USFDA to market its generic Theophylline extended-release tablets for treating asthma and COPD. The approval covers 300 mg and 450 mg strengths. The drug, to be manufactured in Ahmedabad SEZ, had annual US sales of USD 12.6 million.
Zydus Lifesciences inks licensing, supply pact with MSN for generic cancer drug in US market devdiscourse.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from devdiscourse.com Daily Mail and Mail on Sunday newspapers.
Zydus Lifesciences gets USFDA nod for acne treatment gel moneycontrol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from moneycontrol.com Daily Mail and Mail on Sunday newspapers.
Zydus Lifesciences gets USFDA nod for acne treatment gel - The Hindu BusinessLine thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.